EPRX

Eupraxia Pharmaceuticals

11 hedge funds and large institutions have $7.09M invested in Eupraxia Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
+2
Holders Change %
+22.22%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
SC
1
Scotia Capital
Ontario, Canada
$5.07M +$526K +160,960 +12%
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$1.13M +$196K +59,683 +21%
TWC
3
TD Waterhouse Canada
Ontario, Canada
$343K +$343K +104,986 New
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$171K -$14.7K -4,500 -8%
UBS Group
5
UBS Group
Switzerland
$168K +$76.1K +23,199 +83%
Goldman Sachs
6
Goldman Sachs
New York
$113K
Citadel Advisors
7
Citadel Advisors
Florida
$39.4K +$39.4K +12,054 New
Raymond James Financial
8
Raymond James Financial
Florida
$36.5K -$1.57K -480 -4%
JPMorgan Chase & Co
9
JPMorgan Chase & Co
New York
$8.86K +$8.86K +2,700 New
Bank of America
10
Bank of America
North Carolina
$8.2K +$8.2K +2,500 New
National Bank of Canada
11
National Bank of Canada
Quebec, Canada
$2.49K +$2.35K +721 +1,677%
1WA
12
180 Wealth Advisors
Washington
-$33.3K -10,500 Closed
Millennium Management
13
Millennium Management
New York
-$31.3K -10,000 Closed